Related by context. All words. (Click for frequent words.) 69 IgG1 antibody 69 CYT# potent vascular disrupting 69 Pertuzumab 68 Virulizin ® 68 vascular disrupting agents 68 pan HDAC inhibitor 68 Hsp# inhibition 68 thalidomide Thalomid 68 Panzem 68 Inhaled nitric oxide 67 BRAF inhibitor 67 erlotinib Tarceva 67 EGF receptor 67 HuLuc# 67 PARP inhibition 67 Aplidin 67 BRAF inhibitors 67 flavopiridol 66 targeting CD# 66 chimeric monoclonal antibody 66 kidney urologic 66 haematological cancers 66 cilengitide 66 Squalamine 66 Interferon beta 66 Vandetanib 66 neurotrophic 66 somatostatin receptors 66 mTOR mammalian target 66 Temsirolimus 66 selective inhibition 66 AEG# 66 YONDELIS 66 proteasome inhibitors 66 Trastuzumab 66 endocrine therapies 66 anti CD3 antibody 66 anticancer therapy 66 CBLC# 66 trastuzumab Herceptin ® 66 JAK inhibitors 66 noninfectious uveitis 66 mTOR inhibition 66 gefitinib Iressa 66 virotherapy 66 Gleevec resistant 66 immuno modulatory 65 vinca alkaloid 65 antiangiogenic therapy 65 ENMD # 65 humanized monoclonal antibodies 65 triterpenoids 65 PSMA ADC 65 antiproliferative effects 65 chemoresistance 65 Symadex 65 myelofibrosis polycythemia vera 65 protein misfolding diseases 65 A3 adenosine receptor 65 bevacizumab Avastin ® 65 mGluR2 NAM 65 ADAMTS# 65 engineered RAP peptides 65 resolvins 65 BZL# 65 Degarelix 65 therapeutic monoclonal antibody 65 Gefitinib 65 TNF alpha antagonist 65 angiogenesis inhibitor 65 malignant ascites 65 antibody mediated 65 immune modulating 65 mda 7 65 mTOR inhibitors 65 pegylated liposomal doxorubicin 65 inhibit metastasis 65 anti angiogenic agents 65 HuMax EGFr 65 renal fibrosis 65 chemopreventive agent 65 fibrotic disease 65 Factor VIIa 65 HDAC inhibition 65 MAGE A3 ASCI 65 MGd 65 Ceflatonin 65 antiangiogenic 65 multi kinase inhibitor 65 mTOR kinase 65 Sudhir Agrawal D.Phil 65 kinase inhibition 65 biologic pathways 65 cediranib 65 TRAIL induced apoptosis 64 HQK 64 novel peptide 64 pharmacological chaperone 64 Tarvacin 64 relapsed ovarian cancer 64 GRN# 64 neuroprotectant 64 anticancer therapeutics 64 riociguat 64 Curaxin 64 metastatic colorectal 64 VEGF induced 64 novel immunotherapeutic 64 antitumoral 64 immatics 64 SGS# 64 anti angiogenic therapy 64 SSc 64 enzastaurin 64 Protein Kinase C 64 demethylating agent 64 radionuclide therapy 64 investigational monoclonal antibody 64 targeted antifolate 64 targeted radiotherapeutic 64 Vascugel 64 anti fibrotic 64 HSP# inhibitor 64 proteasome inhibitor 64 Aviptadil 64 MEK inhibitors 64 VitiGam 64 Vidofludimus 64 antitumor effects 64 inhibiting mTOR 64 pertuzumab 64 treating neuropathic pain 64 PPARγ 64 masitinib 64 potent antiproliferative 64 molecularly targeted 64 EGFR inhibitors 64 antimetastatic 64 JAK3 64 antimitotic 64 EndoTAGTM 1 64 acadesine 64 Irinotecan 64 effector function 64 tyrosine kinase inhibitor 64 Anthracycline 64 mGluR5 antagonist 64 Nanobody ® 64 PROCHYMAL 64 Belldegrun 64 depsipeptide 64 HCV protease inhibitors 64 NKG2D 64 LHRH antagonists 64 OMP #R# 64 antiangiogenic agent 64 histone deacetylase inhibitor 64 T#I [002] 64 sorafenib Nexavar 63 malignant lymphomas 63 Lpathomab 63 Tarvacin TM 63 PKC# 63 alpha#beta# 63 #ME# 63 Golimumab 63 exon skipping 63 immune modulator 63 alkylating agent 63 apoptosis induced 63 Cyclosporin 63 BAL# [001] 63 Monoclonal antibody 63 ON #.Na 63 AMPK activators 63 Hepatocellular Carcinoma HCC 63 Pemphigus 63 Chronic lymphocytic leukemia 63 antagomirs 63 pain palliation 63 LRP5 63 molecularly targeted therapy 63 Wnt signaling pathway 63 antitumor effect 63 Talabostat 63 telomerase inhibitor 63 RANK ligand 63 androgen receptor AR 63 Onconase 63 DFMO 63 Campath alemtuzumab 63 Six3 63 indibulin 63 drug conjugate 63 haematological malignancies 63 activin 63 cisplatin resistant 63 Surgical resection 63 Shark cartilage 63 Tyrima 63 MEK inhibitor 63 NV1FGF 63 VEGF inhibitors 63 trastuzumab Herceptin 63 Modrenal 63 imexon 63 antitumour 63 molecularly targeted therapies 63 Lixivaptan 63 neovascularization 63 Vidaza azacitidine 63 Adjuvant therapy 63 gastrointestinal stromal tumors GIST 63 DXL# 63 anti CD3 63 imatinib Gleevec 63 Potelligent Technology 63 small molecule activators 63 EGFR tyrosine kinase inhibitors 63 Ataluren 63 Angiolix 63 humanised monoclonal antibody 63 LHRH receptor positive 63 lung fibrosis 63 BiTE 63 beta1 integrin 63 microtubule targeting 63 multitargeted 63 Removab 63 entinostat 63 COX2 63 c myc gene 63 pancreatic adenocarcinoma 63 STAT3 signaling 63 GW# [003] 63 CMV infections 63 Proxinium TM 63 GRNOPC1 contains 63 ADAM# 63 anti angiogenic drugs 63 multiple myeloma MM 63 MEK ERK 63 histone deacetylase HDAC inhibitors 63 HCV replication 63 membranous nephropathy 63 Ii protein 63 interstitial cystitis IC 63 Lisofylline 63 metastatic neuroendocrine tumors 63 thymidylate synthase 63 myoblast therapy 63 TLR9 agonist 63 superficial bladder cancer 63 IGFBP2 63 talabostat 63 humanized monoclonal 63 Lodamin 63 Romidepsin 63 cardiotoxic effects 63 small molecule thrombopoietin 62 telomerase activation 62 CINQUIL 62 IAP inhibitor 62 erlotinib Tarceva ® 62 Pemetrexed 62 IRX 2 62 humanised antibody 62 cytoprotective 62 preclinically 62 biliary tract cancer 62 dyskinetic 62 Glioblastoma Multiforme 62 biotherapy 62 liposomal formulation 62 Angiocept 62 HER2 overexpression 62 constipation OIC 62 ELACYT 62 EGFR pathway 62 rituximab Rituxan 62 Aflibercept 62 Photodynamic therapy PDT 62 anti leukemic 62 OncoVEX GM CSF 62 Fleximer 62 EGFr 62 SNT MC# 62 Aliskiren 62 siRNA therapeutics 62 IMA# 62 gemcitabine Gemzar 62 histone deacetylase HDAC 62 PI3K delta 62 interleukin IL -# 62 immuno oncology 62 immunomodulation 62 Factor VEGF 62 Androgen deprivation therapy 62 Xelox 62 JAK inhibitor 62 pancreatic carcinoma 62 Pseudomonas aeruginosa infections 62 commercialize deforolimus 62 immunopathology 62 JAK2 inhibitors 62 therapeutic modality 62 Pervasis 62 paclitaxel Taxol R 62 antiarrhythmic 62 antiapoptotic 62 oral prodrug 62 PKCi 62 cancer immunotherapies 62 Fenretinide 62 Factor Xa inhibitor 62 VEGF receptor 62 Ebola virus infection 62 gastrointestinal stromal tumors 62 antitumor efficacy 62 R roscovitine 62 Zalypsis 62 neuro endocrine 62 fusion enhancers 62 Hedgehog signaling pathway 62 molecular determinants 62 diabetic kidney 62 lumiliximab 62 neovascularisation 62 Xanafide 62 Glioblastoma multiforme 62 novel immunotherapies 62 mTOR inhibitor 62 p# inhibitor 62 antiplatelet therapies 62 Litx 62 neuroregenerative 62 SERCA2a 62 Afatinib 62 Cetrorelix 62 immune modulation 62 BRAF kinase 62 Hedgehog inhibitor 62 lenalidomide dexamethasone 62 tubulin inhibitor 62 allogeneic HSCT 62 P#X# 62 immunoregulatory 62 endoplasmic reticulum stress 62 cardio metabolic diseases 62 OHR/AVR# 62 oncolytic virus 62 gastrointestinal stromal tumor 62 cardioprotection 62 Sphingomab 62 tkRNAi technology 62 Alequel 62 secretory diarrhea 62 immunoregulation 62 Mipomersen 62 hedgehog pathway 62 metastatic malignant melanoma 62 chemopreventive 62 radiolabeled TM# 62 Zarnestra 62 pediatric acute lymphoblastic 62 immune modulatory 62 Galectin 3 62 PARP inhibitor 62 metastatic gastric 62 Nanobody 62 Zybrestat 62 metastatic lymph nodes 62 Carfilzomib 62 adult mesenchymal stem 62 potent anti angiogenic 62 VEGF inhibition 62 MET amplification 62 IMiDs R 62 HDL Selective Delipidation 62 SUTENT ® 62 fulvestrant 62 prostaglandin synthesis 62 MyVax R 62 demonstrated antitumor activity 62 dasatinib Sprycel 62 osteoclast formation 62 oncogenesis 62 Homspera TM 62 Romiplostim 62 delipidation 62 miglustat 62 oncogenic signaling 62 Azedra 62 Enzastaurin 62 PEGylated interferon 62 Pazopanib 62 THR beta agonist 62 HIF 1α 62 dermatologic diseases 62 Angiotensin converting enzyme 62 immunotoxins 62 refractory metastatic 62 Rasagiline 62 epothilones 62 Photodynamic therapy 62 histone deacetylase inhibitors 62 malignant pheochromocytoma 61 Factor Receptor 61 GRASPA ® 61 oligodendrocyte progenitor cells 61 trans retinoic acid 61 IDH mutations 61 diagnostic biomarker 61 cathepsin K inhibitor 61 potent anticancer 61 CDDO Im 61 Cloretazine 61 BrachySil TM 61 ddRNAi 61 pediatric malignancies 61 gastro intestinal inflammation 61 mitochondrial toxicity 61 Sipuleucel T 61 SGLT2 inhibitors 61 imatinib resistance 61 Mucosal 61 immunotoxin 61 Epidermal Growth Factor Receptor 61 docetaxel Taxotere ® 61 idarubicin 61 hematological malignancy 61 metaglidasen 61 Radioimmunotherapy 61 S#P# 61 EndoTAG TM 61 paclitaxel poliglumex 61 bortezomib Velcade 61 immunological diseases 61 Davanat 61 anticancer therapies 61 opioid receptor antagonist 61 Combo Stent 61 malignant pleural mesothelioma 61 tranilast 61 CD# antibody [001] 61 benign prostatic hypertrophy BPH 61 carcinoid 61 epithelial tumors 61 Bezielle 61 signal transduction inhibitors 61 HER2 positivity 61 chronic periodontitis 61 Amplimexon 61 5 HT6 receptor 61 antisense inhibitors 61 small molecule tyrosine 61 anti CD# antibodies 61 invasive candidiasis 61 Bryostatin 61 Akt activation 61 proliferative disorders 61 TGF beta signaling 61 investigational therapies 61 neoplastic diseases 61 receptor inhibitor 61 Everolimus 61 CXCR4 receptor 61 primary hyperparathyroidism 61 CIPN 61 Intravenous CP 61 plasma kallikrein 61 RANK Ligand 61 anthracycline chemotherapy 61 immunomodulatory effects 61 mutated KRAS gene 61 CEQ# 61 pathophysiological effects 61 Valdoxan 61 hepatoma 61 sclerostin 61 Liprotamase 61 basiliximab 61 oral JAK1 61 recurrent glioblastoma multiforme 61 rxRNA 61 Aplidin R 61 mitochondrial disorders 61 Taxol ® 61 VA# [002] 61 PI3K/mTOR 61 Epstein Barr Virus EBV 61 Arranon 61 #beta HSD1 61 tafamidis 61 cytostatic 61 Upregulation 61 Aurora kinase 61 metastatic uveal melanoma 61 NTDDS 61 demethylating agents 61 Kinoid 61 GRNCM1 61 colorectal carcinoma 61 tumor microenvironment 61 ASPIRE HIGHER 61 imatinib Gleevec ® 61 proteasome inhibition 61 EndoTAG TM -1 61 antioxidant supplementation 61 bispecific antibody 61 chemo resistant 61 Mantle Cell Lymphoma 61 lapatinib Tykerb 61 HER2 receptor 61 recurrent glioblastoma 61 LHRH agonist 61 5 HT4 61 PDGF receptor 61 Decitabine 61 Epratuzumab 61 sCD# 61 Cyclin E 61 CDK inhibitors 61 investigational humanized monoclonal antibody 61 Erlotinib 61 metabonomics 61 monoclonal antibody MAb 61 bone metastasis 61 Taxotere docetaxel 61 parthenolide 61 Provecta TM 61 oral antiviral 61 TroVax ® 61 DNA intercalator 61 cannabinor 61 NXL# 61 Anthracyclines 61 nonsmall cell lung cancer 61 KuDOS 61 histone deacetylases 61 radioimmunotherapy RIT 61 JAK2 inhibitor 61 Pancreate 61 GeneICE 61 Noxafil 61 accumulate preferentially 61 Bleomycin 61 cyclophilin inhibitors 61 E#F# 61 mycosis fungoides 61 vorinostat 61 Zolinza 61 mertansine 61 Campath ® 61 prostate cancer CRPC 61 Vascugel R 61 standard chemotherapy regimen 61 chemotherapeutic drug 61 Lipsovir ® 61 cisplatin gemcitabine 61 differentiated thyroid 61 Revlimid lenalidomide 61 DCVax 61 MYCN amplification 61 EGFR receptor 61 underlying pathophysiology 61 Fc gamma receptor 61 antiangiogenesis 61 TRO# 61 PhG alpha 1 61 EGFR tyrosine kinase inhibitor 61 urothelial cancer 61 novel immunomodulatory 61 Cx# [002] 61 chlamydial 61 dyskeratosis congenita 61 Pier Paolo Pandolfi 61 CB2 receptor 61 monoclonal antibody therapies 61 AKT inhibitor 61 biologic plausibility 61 Gleevec imatinib 61 trabectedin 61 radiation sensitizer 61 breast cancer metastasis 61 vascular disrupting agent 61 intratumoral injection 61 IMiDs ® 61 XmAb# 61 protein tyrosine phosphatases 61 etanercept Enbrel 61 RNAi therapeutic targeting 61 haematologic malignancies 61 menadione 61 pharmacologic approaches 61 IMiDs ® compound 61 tumor hypoxia 61 cyclooxygenase 2 61 ADVEXIN therapy 61 MAPK pathway 61 acetonide FA 61 hematological cancers 61 bleomycin 61 Bendavia 61 Alocrest 61 basal cell carcinoma BCC 61 MYDICAR ® 61 p# MAP kinase 61 Imatinib 61 leukotriene pathway 61 isoform selective 61 antimetabolite 61 MALT lymphoma 61 systemic RNAi therapeutic 61 Glioblastoma Multiforme GBM 61 uricase 61 Tobinick 61 murine models 61 hypoxic tumors 61 humanized antibody 61 Myelodysplastic syndromes MDS 61 abnormal p# 61 thymidylate synthase TS 61 idiopathic pulmonary fibrosis IPF 61 alpha#beta# integrin 61 C5aR 61 NOD mouse 61 mapatumumab 61 personalized immunotherapy 61 Tyrosine Kinase Inhibitor 61 GPIIb IIIa 61 Mepact 61 oxidative stress induction 61 redox active 61 cardio renal 61 protein homeostasis 61 FOLFOX chemotherapy 61 angiogenesis inhibitors 61 OXi# 61 atacicept 61 lymphomas leukemias 60 Prostacyclin 60 p#/CBP 60 chemosensitivity 60 tumorigenicity 60 biologic therapeutics 60 SIRT1 activation 60 inhibits protein synthesis 60 immunotherapeutic vaccine 60 antiinflammatory 60 multikinase inhibitor 60 milatuzumab 60 aromatase inhibitors AIs 60 cellular immunotherapy 60 EGS# 60 lung pancreatic 60 Helicobacter pylori H. pylori 60 DepoVax 60 IMC A# 60 5 fluorouracil leucovorin 60 protein kinase inhibitor 60 Blinatumomab 60 metastatic bladder 60 inhibit angiogenesis 60 Bone marrow transplantation 60 CXB# 60 EBV infection 60 epigenetic therapies 60 systemic fungal infections 60 Adjuvant chemotherapy 60 solid organ transplantation 60 deferiprone 60 PCK# 60 ATL/TV# 60 combinability 60 immunomodulatory 60 eIF 4E 60 recurrent glioma 60 Fc fusion protein 60 amyloid cascade 60 NS4B 60 myelomas 60 IGF 1R inhibitor 60 conventional chemotherapies 60 mediated inhibition 60 PEG SN# 60 Etanercept 60 TLR agonists 60 metastatic malignant 60 CRLX# 60 obatoclax 60 Alemtuzumab 60 Epothilones 60 denileukin diftitox 60 PDE# inhibitors 60 ADP receptor antagonist 60 neurite outgrowth 60 taxane chemotherapy 60 ZOLINZA 60 humoral immunity 60 trastuzumab resistant 60 GVAX ® 60 Immunotherapeutic 60 potent cytotoxic 60 Alzheimer Disease AD 60 pathogenic mechanisms 60 ACZ# 60 Safinamide 60 sunitinib malate 60 peritoneal carcinomatosis 60 Lilly Alimta 60 Retinoic Acid 60 RAF kinase 60 NF kappaB activation 60 gamma secretase inhibitor 60 Abatacept 60 antibody MAb 60 Mitomycin C 60 corticosteroid dexamethasone 60 DHFR 60 BNC# 60 pancreatic colon 60 protein tyrosine phosphatase 1B 60 Deforolimus 60 CTLA 4 60 antiangiogenic agents 60 selective modulator 60 hippocampal neurogenesis 60 unresectable tumors 60 PTHrP 60 antifibrotic 60 therapeutic peptide 60 BMS# 60 systemic RNAi 60 Camptothecin 60 Surgical excision 60 NFkappaB 60 tumor vascularization 60 TLE3 60 apoptotic pathway 60 novel therapeutic antibodies 60 antitumour activity 60 AA amyloidosis 60 SNT-MC#/idebenone 60 Seliciclib 60 chemically modified siRNA 60 Ontak 60 schizophrenia CIAS 60 Vitaxin 60 GIST tumors 60 Dr. Pestell 60 OZURDEX ® 60 paclitaxel Taxol ® 60 regorafenib 60 sorafenib tablets 60 relapsed leukemia 60 Tasimelteon 60 enzyme inhibitor 60 Fibroblast 60 erythropoietic 60 LPA1 receptor 60 Li Fraumeni Syndrome 60 anti angiogenesis 60 LHRH 60 adenosine A2A receptor 60 Smac mimetics 60 Provectus Pharmaceuticals specializes 60 neuroendocrine cancers 60 K ras mutations 60 chemoresistant 60 pelvic malignancies 60 MMP inhibitors 60 TGR5 60 CCR9 antagonist 60 myeloproliferative disorders 60 ARRY # 60 Myelofibrosis 60 mGlu2 3 60 neovascular diseases 60 Pyridorin 60 CB1 antagonists 60 FLT3 60 paclitaxel Taxol 60 MitoQ 60 Glioma 60 Duchenne muscular dystrophy DMD 60 Xcytrin R 60 nicotinic acetylcholine receptor 60 FUSILEV enhances 60 NF kB pathway 60 Tekmira LNP technology 60 glucagon receptor 60 ABL1 60 gastrin 60 Molecular imaging 60 hypereosinophilic syndrome 60 rhITF 60 ZACTIMA 60 NovaBay Aganocide compounds 60 PRT# 60 gp# vaccine 60 nicotinic alpha 7 60 demethylation 60 Curaxin CBLC# 60 drug zotarolimus 60 Non Hodgkins lymphoma 60 HuCNS SC ® 60 BRAF V#E mutation 60 PDE4 inhibitor 60 Epstein Barr virus EBV 60 doxorubicin Adriamycin 60 DAPT 60 HDAC3 60 idiopathic pulmonary 60 Cachexia 60 molecular mimicry 60 Rituxan rituximab 60 MAXY G# 60 cAMP signaling 60 underlying molecular mechanisms 60 delafloxacin 60 Lilly Gemzar 60 olaparib 60 Wnts 60 M1 muscarinic 60 nucleoside analog 60 FGFR3 60 sJIA 60 diseases fat malabsorption 60 TLR9 agonists 60 recurrent glioblastoma multiforme GBM 60 Nurr1 60 Nanobodies ® 60 factor Xa 60 Src inhibitors 60 anti angiogenic agent 60 Trabectedin 60 stratifying patients 60 CCR9 60 adenosine A2A 60 metastatic renal 60 Ceflatonin R 60 hormone deprivation 60 TNFα 60 Prodarsan R 60 Talactoferrin 60 ErbB3 HER3 60 prostate cancer PCa 60 idraparinux 60 Genentech Herceptin 60 ProSavin 60 INGN 60 B Raf 60 Fas ligand 60 FGFR 60 Imprime PGG 60 antitumor immunity 60 Alpha lipoic acid 60 FVIIa 60 endocrine tumors 60 transgenic mouse models 60 cMET 60 Smac mimetic 60 Trofex 60 squamous cell lung cancer 60 Anticalin R 60 intercellular signaling 60 allergic inflammation 60 antisense inhibitor 60 CTGF 60 tubulin binding 60 neuroinflammatory 60 Stapled Peptide 60 triphendiol 60 EphB2 60 Galectin 60 thetreatment 60 STEDESA 60 PEP# [003] 60 adoptive immunotherapy 60 nucleoside analogues 60 pharmacokinetic interactions 60 γ secretase 60 targeting PCSK9 60 indolent NHL 60 kallikrein 60 ganaxolone 60 radiotherapeutic 60 berberine 60 taxane therapy 60 hepatitis C viral infection 60 Aurora Kinase 60 prostate carcinoma 60 Thiovir 60 intracellular signaling pathways 60 TREANDA 60 YONDELIS R 60 antibody humanization 60 Fludara ® 60 Cardiotoxicity 60 thymic carcinoma 60 velafermin 60 busulfan 60 AA Amyloidosis 60 Janus kinase 60 Novartis Zometa 60 TNFerade TM 60 cognitive enhancer 60 Exherin TM 60 XYOTAX TM 60 indolent lymphomas 60 Dasatinib 60 IGF 1R 60 gemcitabine Gemzar ® 60 acute promyelocytic leukemia APL 60 pancreatic islet cell 60 Valproic acid 60 AAV2 60 peptibody 60 ACV1 60 phase IIb trial 60 pharmacokinetic equivalence 60 Myocet 60 TTR amyloidosis 60 rhabdoid 60 miR #a [001] 60 HyACT 60 Olaparib 60 intranasal delivery 60 Helicobacter 60 BEXXAR Therapeutic Regimen 60 annexin 60 Clusterin 60 CCR2 60 Akt inhibitor 60 Histone deacetylase 60 TG# [003] 60 Crizotinib 60 c MET 60 Behcet uveitis 60 thromboembolic disease 60 vidofludimus 60 castrate resistant prostate cancer 60 PLX MS 60 gastrointestinal stromal tumors GISTs 60 Vidaza ® 60 imetelstat 60 #HT#A 60 M2 subunit 60 ErbB3 60 PDE# 60 Archexin 60 HDAC6 60 GSK3 60 PORxin TM 60 specific lectin receptors 60 HGS# 60 MKC# MKC# PP 60 IGF IR 60 CXCR7 60 FGFs 60 OncoVex 60 Wnt beta catenin 60 proton pump 60 Nexavar sorafenib 60 GI motility disorders 60 Abiraterone acetate 60 physiologic mechanisms 60 epigenetic mechanisms 60 poly ADP ribose polymerase 60 ATTR CM 60 #beta HSD 1 60 SYN# 60 farletuzumab 60 lymphangiogenesis 60 Guanilib 60 ERK signaling 60 Preclinical Study 60 Corus CAD 60 antiangiogenic drugs 60 leukemia AML 60 hypophosphatasia 60 Bevacizumab 60 deacetylase inhibitors 60 Capsulution 60 Antitumor Activity 60 pro angiogenic 60 Metastatic colorectal cancer 60 2DG 60 underlying vasculopathy 60 compound AEZS 60 receptor activator 60 Abiraterone 59 RhuDex 59 CGEN # 59 verteporfin 59 DACH platinum 59 teplizumab 59 Sym#